| |  | | | | By Andrew Joseph Joe Raedle/Getty Images New data show those who recovered from Covid-19 were less likely than vaccinated people to get infected during the Delta wave. Read More | | By Helen Branswell Gustavo Garello Caveats abound, but many experts believe that Omicron will have produced so much immunity in populations that we might get a reprieve. Read More | | By Matthew Herper NIH/National Institute of Biomedical Imaging and Bioengineering Altos Therapeutics will bring together some of the biggest names in biotech and a vision for reprogramming the machinery of living cells. Read More | | Sponsor content by STAT Reports How continuous glucose monitors are transforming diabetes care Continuous glucose monitoring, or CGM, is transforming diabetes care. Where a diagnosis once meant a lifetime of finger pricking and injections, these devices now help achieve less invasive monitoring and treatment for the millions of Americans living with diabetes. With prescriptions of CGMs increasing, the question remains – can these devices become the standard of care? Our latest report looks to answer this question, analyzing our best intelligence on the burgeoning industry of CGM, and examining where the industry is likely to head next. | | By Rachel Cohrs Anna Moneymaker/Getty Images Biden just launched a massive, slapdash effort to distribute free Covid-19 tests by mail. Will it backfire? Read More | | By Mario Aguilar Adobe A sweeping new analysis adds up the evidence on smartphone-based apps to treat behavioral health conditions. Read More | | By Ed Silverman J. Scott Applewhite/AP The query is part of an ongoing probe into tax practices by multi-national drug makers and how tax loopholes allow them to avoid U.S. taxes. Read More | | By Holly Fernandez Lynch and Keith Hamilton Pfizer Several states have decided to distribute the Covid-fighting drug Paxlovid to retail pharmacies rather than hospitals. That's a mistake. Read More | | By Adam Feuerstein Adobe The young company’s technology is based on novel discoveries made by Sam Gunderson, a professor of molecular biology at Rutgers University. Read More | | By Dan Michelson Steven Senne/AP Staffing and labor challenges were the No. 1 issue health system CEOs and CFOs shared at this year's J.P. Morgan Health Care Conference. Read More | |
No comments